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Introduction 
Localized amyloid deposition can occur in many 
tissues, in particular in the skin, heart and brain. 
However, focal deposition in the lungs is rare. A case 
of localized pulmonary amyloidosis with resultant 
post-obstructive pneumonia is presented, and the 
management with a combination of laser therapy and 
oral steroids is described. 
Case Report 
A 47-year-old housewife presented with a 3-month 
history of right-sided pleuritic chest pain, repeated 
colds and chest infections, 2 stone weight loss, poor 
appetite and night sweats. She was a smoker of 3 
cigarettes day - ’ but had smoked 20-40 cigarettes 
day- i. Six years previously, she had been investi- 
gated for haemoptysis and had a bronchoscopy 
which showed bronchial mucosal inflammation but 
no endobronchial abnormality. In her past medical 
history, she had whooping cough as a child, a hyster- 
ectomy and recurrent urinary tract infections. In her 
family history, her mother had Crohn’s disease and 
her father had renal disease and died in his thirties. 
Physical examination was unremarkable. 
Chest radiograph showed right upper lobe 
shadowing with loss of volume and a prominent 
right hilum (Plate 1). A computed tomographic (CT) 
scan showed a soft tissue mass around the right 
hilum extending into the precarinal space (Plate 2). 
There was some calcification within the mass. 
Bronchoscopy was performed which showed fleshy 
‘tumour’ occluding the right upper lobe bronchus 
and extending into the bronchus intermedius, which 
bled easily with biopsy. The biopsies showed a 
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Plute I Chest radiograph showing right upper lobe 
shadowing with volume loss and a prominent right hilum. 
number of mucosal glands suspended in a pink 
amorphous material with a foreign body giant cell 
reaction (Plate 3). Special staining with Congo red 
confirmed the presence of amyloid which showed the 
characteristic green birefringence under polarized 
light. The amyloid was resistant to permanganate 
oxidation, in keeping with primary localized amyloid. 
Immunohistochemical staining for amyloid A protein 
seen in systemic amyloidosis was negative. 
Extensive investigations were done to look for 
evidence of systemic amyloidosis or multiple 
myeloma. Bone marrow biopsy, rectal biopsy, ultra- 
sound scanning of the kidneys, creatinine clearance, 
urinary protein, B2 microglobulin and immuno- 
globulins were all normal. Plasma protein electro- 
phoresis showed a non-specific rise in a globulin. 
Echocardiogram showed mild left atria1 enlargement 
and good left ventricular function with an ejection 
fraction of 70%. 
Repeat bronchoscopy was performed about 6 
weeks later which showed that the right upper lobe 
bronchus remained occluded with friable tissue. 
Endobronchial Nd:YAG laser treatment was then 
given on a monthly basis for 6 months. Despite initial 
reduction in the amyloid tissue with this treatment, 
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Plate 2 Computed tomographic scan showing a soft 
tissue mass around the right hilum with calcification and 
extension into the precarinal space. There is also distal lung 
consolidation. 
Plate 3 Photomicrograph showing the amorphous amy- 
Ioid material with a few giant cells (haematoxylin-eosin 
stain, x 400 magnification). 
there was a regrowth of amyloid tissue noted at later 
treatments. For this reason, systemic treatment was 
commenced in the form of oral prednisolone; the 
starting dose was 30 mg daily and this was reduced 
over a 3-week period to a maintenance dose of 10 mg 
daily. Antibiotic prophylaxis against staphylococcal 
pneumonia was also given in the form of flucloxacil- 
lin 250 mg twice daily. A repeat chest radiograph 
showed significant resolution of the right upper lobe 
shadowing (Plate 4). The clinical benefit of oral 
prednisolone appeared clear when the patient 
inadvertently stopped the steroid tablets for 2 weeks 
and developed a recurrence of initial symptoms 
including chest pain, shortness of breath and poor 
energy. These symptoms resolved on recommencing 
prednisolone. 
Approximately 6 months after completion of the 
laser treatment, repeat bronchoscopy was performed. 
Plate 4 Chest radiograph showing good resolution of the 
right upper lobe shadowing. 
Plate 5 Computed tomographic scan showing a small area 
of consolidation in the right upper lobe and calcified hilar 
nodes. 
This showed that the right upper lobe bronchus 
remained occluded, but a pin-hole orifice was seen. A 
repeat CT scan of the chest showed significant 
improvement with only a small area of hilar shadow- 
ing and consolidation in the right upper lobe 
(Plate 5). 
Symptomatically, the patient has improved. After 
2 yr since initial presentation, she suffers from a 
mild chest infection every 34 months which resolves 
following treatment with a broad spectrum oral 
antibiotic. She remains on maintenance low-dose 
oral prednisolone and flucloxacillin. 
Discussion 
Localized pulmonary amyloidosis is a rare 
condition. Three main types have been described (1) 
and include: 
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(1) Focal amyloid deposits in the major airways; 
(2) Single or multiple parenchymal nodules; and 
(3) Diffuse pulmonary infiltrates. 
The patient in the present case had the first type 
described. Clinical presentation was related to the 
presence of endobronchial obstruction. If no 
obstruction is present, the presence of pulmonary 
amyloidosis usually causes no symptoms or occa- 
sional haemoptysis (2). However, without treatment, 
the disease can progress with even a single pulmonary 
nodule developing into multiple nodules in the lung 
(3). Amyloid infiltration can occur into small blood 
vessels and fatal pulmonary haemorrhage has been 
described (4). In the present case, the endobronchial 
lesion bled easily on biopsy, but the patient has had 
no problems with significant haemoptysis. 
Treatment of localized pulmonary amyloidosis, 
as of systemic amyloidosis, is difficult. Often no 
treatment is required as the patient is asymptomatic. 
However, in the present case, the amyloid tumour 
was causing endobronchial obstruction and resultant 
post-obstructive pneumonitis. For this reason, treat- 
ment was directed at relieving the obstruction. 
Thoracotomy with lung resection was considered 
but can be hazardous with the risk of pulmonary 
haemorrhage. Also, in the present case there was 
mediastinal extension of the amyloid tissue so com- 
plete resection would not have been possible. It was, 
therefore, decided to treat with endobronchial laser 
therapy and oral steroids to reduce the size of the 
amyloid lesion. This has been sufficient to partially 
relieve the obstructive symptoms, although further 
laser therapy may be required at a later date. There 
have been previous reports of successful clearance of 
endobronchial amyloid lesions using laser therapy in 
isolation (5,6,7). However, in the present case, 
regrowth of amyloid tissue was noted despite laser 
therapy, therefore systemic treatment was added. Use 
of oral steroids has been described for the treatment 
of systemic amyloidosis (8) but not for localized 
disease, as in the present case. 
In conclusion, localized pulmonary amyloidosis is 
a rare cause of endobronchial obstruction. Treatment 
is directed at relieving the obstruction. The authors 
have described a combined approach using endo- 
bronchial laser therapy, oral steroids and antibiotics 
to control symptoms, thus avoiding surgical resection 
and the concomitant risk of severe pulmonary 
haemorrhage. 
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